Physician profile
Benjamin P Levine
NPI 1750305728
$3,648.64
in general payments reported to CMS, 2019-2025
28 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $205 · 2021: $185 · 2022: $158 · 2023: $2,021 · 2024: $266 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $894.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $1,500.00 | 2023 | |
| Stryker Corporation | $530.48 | 2019-2024 | Gamma, T2 |
| Tricoast Surgical Solutions LLC | $242.00 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $216.62 | 2020-2024 | A.L.P.S., Tapestry |
| Amgen INC. | $153.18 | 2019-2023 | Evenity, Prolia |
| Fidia Pharma USA INC. | $125.59 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $124.55 | 2019 | |
| Pacira Therapeutics, INC. | $115.68 | 2019-2020 | |
| Smith+Nephew, INC. | $96.10 | 2023 | Spatial Frame, N/A, Bone Anchors With Arthroscopic Delivery System |
| Anika Therapeutics, INC. | $78.82 | 2021 | |
| Nextremity Solutions INC. | $62.99 | 2020 | |
| Myriad Genetic Laboratories, INC. | $43.00 | 2023 | Myrisk |
| Bioventus LLC | $33.80 | 2020 | |
| Depuy Synthes Sales INC. | $32.67 | 2019-2023 | Na |
| Ethicon US, LLC | $31.65 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $31.56 | 2024 | Osteomed |
| Pacira Pharmaceuticals Incorporated | $28.89 | 2025 | Exparel |
| Si-Bone, INC. | $26.07 | 2021 | |
| Endo Pharmaceuticals INC. | $20.79 | 2023 | Xiaflex |
| Sanofi-Aventis U.S. LLC | $19.86 | 2022 | |
| Linvatec Corporation | $19.40 | 2019 | |
| Integra Lifesciences Corporation | $19.20 | 2023 | Tenoglide |
| Boston Scientific Corporation | $18.10 | 2021 | |
| Abbvie INC. | $16.60 | 2022 | |
| Medtronic USA, INC. | $16.14 | 2019 | |
| Djo, LLC | $15.86 | 2019 | |
| Radius Health, INC. | $15.49 | 2022 | |
| Axogen | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.